Confidence limits for contribution plots in multivariate statistical process control using bootstrap estimates.
Hamid Babamoradi, Frans van den Berg, Åsmund Rinnan
https://pubmed.ncbi.nlm.nih.gov/26826689/Actively Recruiting
Led by Antonella Costantino · Updated on 2026-02-20
400
Participants Needed
3
Research Sites
N/A
Total Duration
Researchers are studying children with Autism Spectrum Disorders ASD aged 0 to 11 years to evaluate the impact of ongoing real-life treatments provided in three different National Health Service settings. This observational study aims to explore multidimensional and comprehensive outcome measures that reflect global functioning, quality of life, and shared decision making. The study addresses the need for more integrated and long-term evaluation tools in ASD care, following Italian national guidelines. Participants will continue their usual treatments in line with national autism guidelines at different health facilities, representing diverse service organizations. New outcome tools, including the Child and Adolescent Needs and Strengths CANS scale, the Developmental Disabilities-Child Global Assessment Scale DD-CGAS, and the Pediatric Quality of Life Inventory PedsQL, will be used to assess changes pre- and post-intervention. The study will investigate correlations between these tools and identify clusters related to needs and strengths. During the study, children will undergo assessments using these scales from March 2025 to August 2026 to measure global functioning, quality of life, and evolving needs. Researchers will evaluate the acceptability and usefulness of the outcome tools for clinicians, patients, and families, as well as their sustainability in daily practice. The primary outcome focuses on identifying specific CANS item clusters that differentiate user profiles at baseline, with several secondary outcomes measuring changes over time.
CONDITIONS
Pilot Study on Collaborative, Comprehensive, Multidimensional and Quality of Life Tools for Priority Definition, Shared Decision Making, Outcome Evaluation and Quality of Care Improvement in ASD Individuals and Programs in the Real World.
M
Maria Antonella Costantino
D
Debora Zanolla
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Antonella Costantino
Lead Sponsor
IRCCS Eugenio Medea
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From March 2025 to August 2026
Participants who undergo routine care are observed using standardized tools to assess needs, strengths, global functioning, and quality of life over time.
Multiple assessments during routine healthcare visits over the study period
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Hamid Babamoradi, Frans van den Berg, Åsmund Rinnan
https://pubmed.ncbi.nlm.nih.gov/26826689/Priscilla Brandi Gomes Godoy, Fernando Mitsuo Sumiya, Leonardo Seda...
https://pubmed.ncbi.nlm.nih.gov/35751600/Umberto Provenzani, Laura Fusar-Poli, Natascia Brondino...
https://pubmed.ncbi.nlm.nih.gov/31269800/Micheal Sandbank, James E Pustejovsky, Kristen Bottema-Beutel...
https://pubmed.ncbi.nlm.nih.gov/38913359/Ari Ne'eman
https://pubmed.ncbi.nlm.nih.gov/34351268/N Perry, K A Boulton, A Hodge...
https://pubmed.ncbi.nlm.nih.gov/38597587/Antonella Costantino
Lead Sponsor
IRCCS Eugenio Medea
Collaborating Sponsor